oseltamivir
OSELTAMIVIR PHOSPHATE (oseltamivir) is 12. Approved for acute, uncomplicated illness due to influenza a, b infection in patients 2 weeks of age and 3 more indications. First approved in 2017.
Drug data last refreshed 6h ago
12.1 Mechanism of Action Oseltamivir is an antiviral drug with activity against influenza virus [see ] . 12.3 Pharmacokinetics Absorption and Bioavailability Oseltamivir is absorbed from the gastrointestinal tract after oral administration of oseltamivir phosphate and is extensively converted…
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects
Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks
IMU-838 and Oseltamivir in the Treatment of COVID-19